Tech Company Financing Transactions
Mithradote Bio Funding Round
On 10/2/2024, Mithradote Bio announced $1 million in Seed financing from Vickers Venture Partners and private investors.
Transaction Overview
Company Name
Announced On
10/2/2024
Transaction Type
Venture Equity
Amount
$1,000,000
Round
Seed
Investors
Vickers Venture Partners (Lead Investor)
Proceeds Purpose
The company intends to use the funds to advance development of M-101, a novel sublingual self-administered antidote against a spectrum of "date-rape" drugs, and initiate another pipeline program.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Undisclosed
San Diego, CA Undisclosed
USA
San Diego, CA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Mithradote Bio is a biotechnology company developing a novel medication to help prevent drug-facilitated sexual assault.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sophia Lee
President
Jane Lee
Browse more venture capital transactions:
Prev: 10/2/2024: Triveni Bio venture capital transaction
Next: 10/2/2024: BMLL venture capital transaction
Share this article
About Database of VC Transactions
We report on every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs